首页> 外文期刊>American Journal of Dermatopathology >Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: A clinicopathological and immunohistochemical study of 70 cases
【24h】

Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: A clinicopathological and immunohistochemical study of 70 cases

机译:MITF-1和SOX10诊断效用和比较免疫组织化学分析,以原位和光化角膜病区分黑素瘤:70例临床病理和免疫组化研究

获取原文
获取原文并翻译 | 示例
           

摘要

The histologic assessment of intraepidermal melanocytic proliferations involving sun-damaged skin may be challenging in scant biopsy material. Melanoma in situ may occasionally be confused with intraepidermal melanocytic hyperplasia on sun-damaged skin; thus, dermatopathologists may use immunohistochemical studies to help distinguish these entities. Historically, melanoma antigen recognized by T-cells 1 (MART-1) has been regarded as a valuable stain to confirm intraepidermal melanocytes; however, MART-1 may overestimate the number of melanocytes because it labels the melanoma dendrites and might also label pigmented keratinocytes, including structures mimicking junctional melanocytic nests in the setting of a lichenoid infiltrate. A total of 70 cases were retrospectively chosen, including 50 cases of melanoma in situ and 20 cases of actinic keratoses. SOX10 and microphthalmia transcription factor 1 (MITF-1) were performed in all cases. In all cases, the number of cells within epidermis that were identified as melanocytes by immunohistochemistry was compared with the number of melanocytes observed by morphology on hematoxylin and eosin sections. All cases of melanoma in situ showed expression of SOX10; however, the proportion of atypical melanocytes showing strong nuclear positivity was variable and did not approach that seen in MITF-1. There was no expression of either MITF-1 or SOX10 in adjacent pigmented keratinocytes in the cases of actinic keratoses. Both MITF-1 and SOX10 can be used to differentiate melanoma in situ from actinic keratosis with melanocytic hyperplasia; however, MITF-1 exhibits slight superior sensitivity and seems to be a more effective immunostain than SOX10 for the identification and quantification of melanocytes in the setting of melanoma in situ, especially in cases where there is limited tissue.
机译:涉及太阳损伤皮肤的脑内黑素细胞增殖的组织学评估可能是粗糙的活检材料的挑战。黑色素瘤原位可能偶尔与太阳损伤皮肤的脑内黑素细胞增生混淆;因此,皮肤病学家可以使用免疫组化学研究来帮助区分这些实体。从历史上看,T细胞1(MART-1)认识到的黑色素瘤抗原被认为是有价值的污渍,以确认脑内黑色细胞;然而,MART-1可能会估量黑色细胞的数量,因为它标记了黑色素瘤树枝状细胞,也可以标记着色的角质形成细胞,包括模拟的结构模仿结丝细胞巢在凝固浸润的凝固中。回顾性地选择了70例,包括50例黑色素瘤,原位和20例光碱角膜。在所有情况下进行SOX10和微咽喉转录因子1(MITF-1)。在所有情况下,与免疫组织化学鉴定为黑色细胞的表皮内的细胞数量与通过血毒素和曙红切片的形态观察到的黑色细胞数。所有黑色素瘤都出于原位的情况表明SOX10的表达;然而,出现强烈核阳性的非典型黑色细胞的比例是可变的,并且在MITF-1中没有观察到的方法。在邻近的色素角质细胞中,在邻近的色谱角质细胞中没有表达MITF-1或SOX10。 MITF-1和SOX10均可用于将黑素瘤与Melanocytic增生区分化原位;然而,MITF-1表现出轻微的优异敏感性,并且似乎是SOX10比SOX10更有效,用于鉴定和定量黑色素细胞在黑色素瘤的情况下原位,特别是在有有限组织的情况下。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号